| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Dyadic International (NASDAQ:DYAI) through any online brokerage.
Other companies in Dyadic International’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Dyadic International has a consensus price target of $4.50.
The stock price for Dyadic International (NASDAQ: DYAI) is $0.3801 last updated October 20, 2026 at 9:16 AM EDT.
There are no upcoming dividends for Dyadic International.
Dyadic International does not have any upcoming earnings scheduled.
There is no upcoming split for Dyadic International.
Dyadic International is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
